Drug Prices
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2018 data.
The pharmaceutical industry’s latest “report” is an obvious attempt to divert attention away from a problem of their own making: skyrocketing drug prices.
Senate Finance Committee leaders Friday released changes to the Prescription Drug Pricing Reduction Act that would eliminate impending Medicaid cuts to disproportionate share hospitals for two years.
The latest report from AIR340B continues to misrepresent a program with a more than 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive health services for the many patients served by participating…
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
AHA's comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
The House Ways and Means Committee last night voted 24-17 to approve a revised version of the Lower Prescription Drug Costs Now Act.
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
Two House committees today marked up revised versions of the Lower Prescription Drug Costs Now Act (H.R. 3) — legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.